Price trends and affordability of metastatic non–small cell lung cancer drugs in China from 2019 to 2024

Xin Du(Vanke (China)), Yi Zhang(Vanke (China)), Xingxian Luo(Peking University), Lin Huang(Sun Yat-sen University), Lizong Li(Peking University), Xufeng Lv(National Medical Products Administration)
The Lancet Regional Health - Western Pacific
February 1, 2025
Cited by 0


Related Papers